The Mechanism of Important Components in Canine Fecal Microbiota Transplantation
Abstract
:Simple Summary
Abstract
1. Introduction
2. Functional Components in Canine FMT
2.1. Microbiota
2.1.1. Commensal Bacteria
2.1.2. Phages and Commensal Fungi
2.2. Metabolites
2.3. Immunoglobulin A
3. The Mechanism of Important Components Acting in FMT
3.1. Affecting the Microbiota
3.1.1. Commensal Bacteria, Viruses, and Fungi
3.1.2. Bile Acids and IgA
3.2. Maintaining the Intestinal Barrier
3.2.1. Bacteria
3.2.2. SCFAs and Bile Acids
3.3. Anti-Inflammation
3.3.1. Commensal Bacterial, Viruses and Fungi
3.3.2. SCFAs and Bile Acids
4. Discussions
4.1. Other Components in Feces May Be Functional in FMT
4.2. FMT May Be Effective in Many Other Diseases of Dogs
4.3. FMT in Veterinary Clinics
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- D’Haens, G.R.; Jobin, C. Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection. Gastroenterology 2019, 157, 624–636. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wortelboer, K.; Nieuwdorp, M.; Herrema, H. Fecal microbiota transplantation beyond Clostridioides difficile infections. eBioMedicine 2019, 44, 716–729. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, K.; Zhou, X.; Zhong, Z.; Liu, H.; Li, M.; Peng, G.; Zhou, Z. Indications for Canine Fecal Microbiota Transplantation. Thai J. Vet. Med. 2022, 52, 13–21. [Google Scholar]
- Sugita, K.; Yanuma, N.; Ohno, H.; Takahashi, K.; Kawano, K.; Morita, H.; Ohmori, K. Oral faecal microbiota transplantation for the treatment of Clostridium difficile-associated diarrhoea in a dog: A case report. BMC Vet. Res. 2019, 15, 11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Niina, A.; Kibe, R.; Suzuki, R.; Yuchi, Y.; Teshima, T.; Matsumoto, H.; Kataoka, Y.; Koyama, H. Improvement in Clinical Symptoms and Fecal Microbiome After Fecal Microbiota Transplantation in a Dog with Inflammatory Bowel Disease. Vet. Med. Res. Rep. 2019, 10, 197–201. [Google Scholar] [CrossRef] [Green Version]
- Bottero, E.; Benvenuti, E.; Ruggiero, P. Fecal Microbiota Transplantation (Fmt) in 16 Dogs with Idiopatic Ibd. Veterinaria 2017, 31, 31–45. [Google Scholar]
- Bryan, C.E.; Cade, J.C.; Mackin, A.J.; Sullivant, A.M. Evaluation of a structured individualised protocol as a potential cost-effective diagnostic and therapeutic approach to chronic diarrhoea in the dog. Vet. Med. Sci. 2019, 5, 210–221. [Google Scholar] [CrossRef]
- Pereira, G.Q.; Gomes, L.A.; Santos, I.S.; Alfieri, A.; Weese, J.S.; Costa, M.C. Fecal microbiota transplantation in puppies with canine parvovirus infection. J. Vet. Intern. Med. 2018, 32, 707–711. [Google Scholar] [CrossRef]
- Chaitman, J.; Ziese, A.-L.; Pilla, R.; Minamoto, Y.; Blake, A.B.; Guard, B.C.; Isaiah, A.; Lidbury, J.A.; Steiner, J.M.; Unterer, S.; et al. Fecal Microbial and Metabolic Profiles in Dogs With Acute Diarrhea Receiving Either Fecal Microbiota Transplantation or Oral Metronidazole. Front. Vet. Sci. 2020, 7, 192. [Google Scholar] [CrossRef]
- Gal, A.; Barko, P.C.; Biggs, P.J.; Gedye, K.R.; Midwinter, A.C.; Williams, D.A.; Burchell, R.K.; Pazzi, P. One dog’s waste is another dog’s wealth: A pilot study of fecal microbiota transplantation in dogs with acute hemorrhagic diarrhea syndrome. PLoS ONE 2021, 16, e0250344. [Google Scholar] [CrossRef]
- Bojanova, D.P.; Bordenstein, S.R. Fecal Transplants: What Is Being Transferred? PLoS Biol. 2016, 14, e1002503. [Google Scholar] [CrossRef]
- Ott, S.J.; Waetzig, G.H.; Rehman, A.; Moltzau-Anderson, J.; Bharti, R.; Grasis, J.A.; Cassidy, L.; Tholey, A.; Fickenscher, H.; Seegert, D.; et al. Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection. Gastroenterology 2017, 152, 799–811.e7. [Google Scholar] [CrossRef]
- Coelho, L.P.; Kultima, J.R.; Costea, P.I.; Fournier, C.; Pan, Y.; Czarnecki-Maulden, G.; Hayward, M.R.; Forslund, S.K.; Schmidt, T.S.B.; Descombes, P.; et al. Similarity of the dog and human gut microbiomes in gene content and response to diet. Microbiome 2018, 6, 72. [Google Scholar] [CrossRef]
- Swanson, K.; Dowd, S.; Suchodolski, J.; Middelbos, I.S.; Vester, B.M.; Barry, K.A.; Nelson, K.E.; Torralba, M.; Henrissat, B.; Coutinho, P.M.; et al. Phylogenetic and gene-centric metagenomics of the canine intestinal microbiome reveals similarities with humans and mice. ISME J. 2010, 5, 639–649. [Google Scholar] [CrossRef]
- Kröger, S.; Vahjen, W.; Zentek, J. Influence of Lignocellulose and Low or High Levels of Sugar Beet Pulp on Nutrient Digestibility and the Fecal Microbiota in Dogs. J. Anim. Sci. 2017, 95, 1598–1605. [Google Scholar] [CrossRef]
- Sandri, M.; Dal Monego, S.; Conte, G.; Sgorlon, S.; Stefanon, B. Raw meat based diet influences faecal microbiome and end products of fermentation in healthy dogs. BMC Vet. Res. 2017, 13, 65. [Google Scholar] [CrossRef]
- Igarashi, H.; Maeda, S.; Ohno, K.; Horigome, A.; Odamaki, T.; Tsujimoto, H. Effect of Oral Administration of Metronidazole or Prednisolone on Fecal Microbiota in Dogs. PLoS ONE 2014, 9, e107909. [Google Scholar] [CrossRef]
- Kim, J.; An, J.-U.; Kim, W.; Lee, S.; Cho, S. Differences in the gut microbiota of dogs (Canis lupus familiaris) fed a natural diet or a commercial feed revealed by the Illumina MiSeq platform. Gut Pathog. 2017, 9, 68. [Google Scholar] [CrossRef] [Green Version]
- Salas-Mani, A.; Jeusette, I.; Castillo, I.; Manuelian, C.L.; Lionnet, C.; Iraculis, N.; Sanchez, N.; Fernández, S.; Vilaseca, L.; Torre, C. Fecal Microbiota Composition Changes after a Bw Loss Diet in Beagle Dogs. J. Anim. Sci. 2018, 96, 3102–3111. [Google Scholar] [CrossRef]
- Foster, M.L.; Dowd, S.; Stephenson, C.; Steiner, J.M.; Suchodolski, J.S. Characterization of the Fungal Microbiome (Mycobiome) in Fecal Samples from Dogs. Vet. Med. Int. 2013, 2013, 658373. [Google Scholar] [CrossRef] [Green Version]
- Handl, S.; Dowd, S.E.; Garcia-Mazcorro, J.F.; Steiner, J.M.; Suchodolski, J.S. Massive parallel 16S rRNA gene pyrosequencing reveals highly diverse fecal bacterial and fungal communities in healthy dogs and cats. FEMS Microbiol. Ecol. 2011, 76, 301–310. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Moodley, A.; Kot, W.; Nälgård, S.; Jakociune, D.; Neve, H.; Hansen, L.H.; Guardabassi, L.; Vogensen, F.K. Isolation and characterization of bacteriophages active against methicillin-resistant Staphylococcus pseudintermedius. Res. Vet. Sci. 2019, 122, 81–85. [Google Scholar] [CrossRef] [PubMed]
- Sekulovic, O.; Garneau, J.; Néron, A.; Fortier, L.-C. Characterization of Temperate Phages Infecting Clostridium difficile Isolates of Human and Animal Origins. Appl. Environ. Microbiol. 2014, 80, 2555–2563. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- O’Mahony, D.; Murphy, K.B.; MacSharry, J.; Boileau, T.; Sunvold, G.; Reinhart, G.; Kiely, B.; Shanahan, F. Portrait of a canine probiotic Bifidobacterium—From gut to gut. Vet. Microbiol. 2009, 139, 106–112. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kelley, R.L.; Minikhiem, D.; Kiely, B.; O’Mahony, L.; O’Sullivan, D.; Boileau, T.; Park, J.S. Clinical benefits of probiotic canine-derived Bifidobacterium animalis strain AHC7 in dogs with acute idiopathic diarrhea. Vet. Ther. 2009, 10, 121–130. [Google Scholar]
- Kainulainen, V.; Tang, Y.; Spillmann, T.; Kilpinen, S.; Reunanen, J.; Saris, P.E.J.; Satokari, R. The canine isolate Lactobacillus acidophilus LAB20 adheres to intestinal epithelium and attenuates LPS-induced IL-8 secretion of enterocytes in vitro. BMC Microbiol. 2015, 15, 4. [Google Scholar] [CrossRef] [Green Version]
- Tang, Y. Isolation, Characterization and Strain-Specific Detection of Canine-Derived Lactobacillus Acidophilus. Ph.D. Thesis, University of Helsinki, Helsinki, Finland, 2014. [Google Scholar]
- Nagaro, K.J.; Phillips, S.T.; Cheknis, A.K.; Sambol, S.P.; Zukowski, W.E.; Johnson, S.; Gerding, D.N. Nontoxigenic Clostridium Difficile Protects Hamsters against Challenge with Historic and Epidemic Strains of Toxigenic Bi/Nap1/027 C. Difficile. Antimicrob. Agents Chemother. 2013, 57, 5266–5270. [Google Scholar] [CrossRef] [Green Version]
- Wang, S.; Heuler, J.; Wickramage, I.; Sun, X. Genomic and Phenotypic Characterization of the Nontoxigenic Clostridioides difficile Strain CCUG37785 and Demonstration of Its Therapeutic Potential for the Prevention of C. difficile Infection. Microbiol. Spectr. 2022, 10, e01788-21. [Google Scholar] [CrossRef]
- Kawade, Y.; Sakai, M.; Okamori, M.; Morita, M.; Mizushima, K.; Ueda, T.; Takagi, T.; Naito, Y.; Itoh, Y.; Shimada, T. Administration of Live, but Not Inactivated, Faecalibacterium prausnitzii Has a Preventive Effect on Dextran Sodium Sulfate-Induced Colitis in Mice. Mol. Med. Rep. 2019, 20, 25–32. [Google Scholar] [CrossRef]
- Breyner, N.M.; Michon, C.; de Sousa, C.S.; Vilas Boas, P.B.; Chain, F.; Azevedo, V.A.; Langella, P.; Chatel, J.M. Microbial Anti-Inflammatory Molecule (Mam) from Faecalibacterium Prausnitzii Shows a Protective Effect on Dnbs and Dss-Induced Colitis Model in Mice through Inhibition of Nf-Κb Pathway. Front. Microbiol. 2017, 8, 114. [Google Scholar] [CrossRef] [Green Version]
- Bian, X.; Wu, W.; Yang, L.; Lv, L.; Wang, Q.; Li, Y.; Ye, J.; Fang, D.; Wu, J.; Jiang, X.; et al. Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice. Front. Microbiol. 2019, 10, 2259. [Google Scholar] [CrossRef] [Green Version]
- Fabia, R.; Ar’Rajab, A.; Johansson, M.L.; Willén, R.; Andersson, R.; Molin, G.; Bengmark, S. The Effect of Exogenous Administration of Lactobacillus Reuteri R2lc and Oat Fiber on Acetic Acid-Induced Colitis in the Rat. Scand. J. Gastroenterol. 1993, 28, 155–162. [Google Scholar] [CrossRef]
- Chan, J.L.; Wu, S.; Geis, A.L.; Chan, G.V.; Gomes, T.A.M.; Beck, S.E.; Wu, X.; Fan, H.; Tam, A.J.; Chung, L.; et al. Non-toxigenic Bacteroides fragilis (NTBF) administration reduces bacteria-driven chronic colitis and tumor development independent of polysaccharide A. Mucosal Immunol. 2019, 12, 164–177. [Google Scholar] [CrossRef]
- Crouzet, L.; Rigottier-Gois, L.; Serror, P. Potential use of probiotic and commensal bacteria as non-antibiotic strategies against vancomycin-resistant enterococci. FEMS Microbiol. Lett. 2015, 362, fnv012. [Google Scholar] [CrossRef]
- Rossi, G.; Pengo, G.; Caldin, M.; Piccionello, A.P.; Steiner, J.M.; Cohen, N.D.; Jergens, A.E.; Suchodolski, J.S. Comparison of Microbiological, Histological, and Immunomodulatory Parameters in Response to Treatment with Either Combination Therapy with Prednisone and Metronidazole or Probiotic VSL#3 Strains in Dogs with Idiopathic Inflammatory Bowel Disease. PLoS ONE 2014, 9, e94699. [Google Scholar] [CrossRef]
- Arslan, H.H.; Aksu, D.S.; Terzi, G.; Nisbet, C. Therapeutic Effects of Probiotic Bacteria in Parvoviral Enteritis in Dogs. Rev. Med. Vet-Toulouse 2012, 2, 55–59. [Google Scholar]
- Dahlman, S.; Avellaneda-Franco, L.; Barr, J.J. Phages to Shape the Gut Microbiota? Curr. Opin. Biotechnol. 2021, 68, 89–95. [Google Scholar] [CrossRef]
- Van Belleghem, J.D.; Dąbrowska, K.; Vaneechoutte, M.; Barr, J.J.; Bollyky, P.L. Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System. Viruses 2018, 11, 10. [Google Scholar] [CrossRef] [Green Version]
- Chehoud, C.; Dryga, A.; Hwang, Y.; Nagy-Szakal, D.; Hollister, E.B.; Luna, R.A.; Versalovic, J.; Kellermayer, R.; Bushman, F.D. Transfer of Viral Communities between Human Individuals during Fecal Microbiota Transplantation. Mbio 2016, 7, e00322. [Google Scholar] [CrossRef] [Green Version]
- Xue, Y.; Zhai, S.; Wang, Z.; Ji, Y.; Wang, G.; Wang, T.; Wang, X.; Xi, H.; Cai, R.; Zhao, R.; et al. The Yersinia Phage X1 Administered Orally Efficiently Protects a Murine Chronic Enteritis Model Against Yersinia enterocolitica Infection. Front. Microbiol. 2020, 11, 351. [Google Scholar] [CrossRef] [Green Version]
- Watanabe, R.; Matsumoto, T.; Sano, G.; Ishii, Y.; Tateda, K.; Sumiyama, Y.; Uchiyama, J.; Sakurai, S.; Matsuzaki, S.; Imai, S.; et al. Efficacy of Bacteriophage Therapy against Gut-Derived Sepsis Caused by Pseudomonas aeruginosa in Mice. Antimicrob. Agents Chemother. 2007, 51, 446–452. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nale, J.Y.; Spencer, J.; Hargreaves, K.R.; Buckley, A.M.; Trzepiński, P.; Douce, G.R.; Clokie, M.R.J. Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo. Antimicrob. Agents Chemother. 2016, 60, 968–981. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zuo, T.; Wong, S.H.; Lam, K.; Lui, R.; Cheung, K.; Tang, W.; Ching, J.Y.L.; Chan, P.K.S.; Chan, M.C.W.; Wu, J.C.Y.; et al. Bacteriophage Transfer During Faecal Microbiota Transplantation in Clostridium Difficile Infection Is Associated with Treatment Outcome. Gut 2018, 67, 634–643. [Google Scholar] [PubMed] [Green Version]
- Martins, F.S.; Elian, S.D.; Vieira, A.T.; Tiago, F.C.; Martins, A.K.; Silva, F.C.; Souza, L.; Sousa, L.P.; Araújo, H.R.; Pimenta, P.F.; et al. Oral treatment with Saccharomyces cerevisiae strain UFMG 905 modulates immune responses and interferes with signal pathways involved in the activation of inflammation in a murine model of typhoid fever. Int. J. Med. Microbiol. 2011, 301, 359–364. [Google Scholar] [CrossRef] [PubMed]
- Tiago, F.; Porto, B.; Ribeiro, N.; Moreira, L.; Arantes, R.; Vieira, A.; Teixeira, M.; Generoso, S.; Nascimento, V.; Martins, F.; et al. Effect of Saccharomyces cerevisiae strain UFMG A-905 in experimental model of inflammatory bowel disease. Benef. Microbes 2015, 6, 807–815. [Google Scholar] [CrossRef]
- Sun, S.; Xu, X.; Liang, L.; Wang, X.; Bai, X.; Zhu, L.; He, Q.; Liang, H.; Xin, X.; Wang, L.; et al. Lactic Acid-Producing Probiotic Saccharomyces cerevisiae Attenuates Ulcerative Colitis via Suppressing Macrophage Pyroptosis and Modulating Gut Microbiota. Front. Immunol. 2021, 12, 777665. [Google Scholar] [CrossRef]
- Håkenåsen, I.M.; Øverland, M.; Ånestad, R.; Åkesson, C.P.; Sundaram, A.Y.; Press, C.M.; Mydland, L.T. Gene expression and gastrointestinal function is altered in piglet small intestine by weaning and inclusion of Cyberlindnera jadinii yeast as a protein source. J. Funct. Foods 2020, 73, 104118. [Google Scholar] [CrossRef]
- Arpaia, N.; Campbell, C.; Fan, X.; Dikiy, S.; Van Der Veeken, J.; Deroos, P.; Liu, H.; Cross, J.R.; Pfeffer, K.; Coffer, P.J.; et al. Metabolites Produced by Commensal Bacteria Promote Peripheral Regulatory T-Cell Generation. Nature 2013, 504, 451–455. [Google Scholar] [CrossRef] [Green Version]
- Parada Venegas, D.; De la Fuente, M.K.; Landskron, G.; González, M.J.; Quera, R.; Dijkstra, G.; Harmsen, H.J.; Faber, K.N.; Hermoso, M.A. Short Chain Fatty Acids (Scfas)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Front. Immunol. 2019, 10, 277. [Google Scholar] [CrossRef] [Green Version]
- Fluitman, K.S.; De Clercq, N.C.; Keijser, B.J.; Visser, M.; Nieuwdorp, M.; Ijzerman, R.G. The intestinal microbiota, energy balance, and malnutrition: Emphasis on the role of short-chain fatty acids. Expert Rev. Endocrinol. Metab. 2017, 12, 215–226. [Google Scholar] [CrossRef] [Green Version]
- Wong, J.M.; de Souza, R.; Kendall, C.W.; Emam, A.; Jenkins, D.J. Colonic Health: Fermentation and Short Chain Fatty Acids. J. Clin. Gastroenterol. 2006, 40, 235–243. [Google Scholar] [CrossRef] [PubMed]
- Vieira, E.L.; Leonel, A.J.; Sad, A.P.; Beltrão, N.R.; Costa, T.F.; Ferreira, T.M.; Gomes-Santos, A.C.; Faria, A.M.; Peluzio, M.C.; Cara, D.C.; et al. Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. J. Nutr. Biochem. 2012, 23, 430–436. [Google Scholar] [CrossRef] [PubMed]
- Tian, Y.; Xu, Q.; Sun, L.; Ye, Y.; Ji, G. Short-chain fatty acids administration is protective in colitis-associated colorectal cancer development. J. Nutr. Biochem. 2018, 57, 103–109. [Google Scholar] [CrossRef] [PubMed]
- Fiorucci, S.; Distrutti, E. Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders. Trends Mol. Med. 2015, 21, 702–714. [Google Scholar] [CrossRef] [PubMed]
- Kang, J.D.; Myers, C.J.; Harris, S.C.; Kakiyama, G.; Lee, I.-K.; Yun, B.-S.; Matsuzaki, K.; Furukawa, M.; Min, H.-K.; Bajaj, J.S.; et al. Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile: Role of Secondary Bile Acids. Cell Chem. Biol. 2019, 26, 27–34. [Google Scholar] [CrossRef] [Green Version]
- Van den Bossche, L.; Hindryckx, P.; Devisscher, L.; Devriese, S.; Van Welden, S.; Holvoet, T.; Vilchez-Vargas, R.; Vital, M.; Pieper, D.H.; Van den Bussche, J.; et al. Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice. Appl. Environ. Microbiol. 2017, 83, e02766-16. [Google Scholar] [CrossRef] [Green Version]
- Grellet, A.; Heilmann, R.M.; Polack, B.; Feugier, A.; Boucraut-Baralon, C.; Grandjean, D.; Grützner, N.; Suchodolski, J.S.; Steiner, J.M.; Chastant-Maillard, S. Influence of Breed Size, Age, Fecal Quality, and Enteropathogen Shedding on Fecal Calprotectin and Immunoglobulin a Concentrations in Puppies During the Weaning Period. J. Vet. Intern. Med. 2016, 30, 1056–1064. [Google Scholar] [CrossRef] [Green Version]
- Okai, S.; Usui, F.; Yokota, S.; Hori-I, Y.; Hasegawa, M.; Nakamura, T.; Kurosawa, M.; Okada, S.; Yamamoto, K.; Nishiyama, E.; et al. High-affinity monoclonal IgA regulates gut microbiota and prevents colitis in mice. Nat. Microbiol. 2016, 1, 16103. [Google Scholar] [CrossRef]
- Chiari, E.F.; Weiss, W.; Simon, M.R.; Kiessig, S.T.; Pulse, M.; Brown, S.C.; Gerding, H.R.; Mandago, M.; Gisch, K.; von Eichel-Streiber, C. Oral Immunotherapy With Human Secretory Immunoglobulin A Improves Survival in the Hamster Model of Clostridioides difficile Infection. J. Infect. Dis. 2021, 224, 1394–1397. [Google Scholar] [CrossRef]
- Kumar, V.; Fischer, M. Expert opinion on fecal microbiota transplantation for the treatment of Clostridioides difficile infection and beyond. Expert Opin. Biol. Ther. 2020, 20, 73–81. [Google Scholar] [CrossRef]
- Park, J.S.; Guevarra, R.B.; Kim, B.R.; Lee, J.H.; Lee, S.H.; Cho, J.H.; Kim, H.; Cho, J.H.; Song, M.; Lee, J.H.; et al. Intestinal Microbial Dysbiosis in Beagles Naturally Infected with Canine Parvovirus. J. Microbiol. Biotechnol. 2019, 29, 1391–1400. [Google Scholar] [CrossRef]
- Broecker, F.; Klumpp, J.; Schuppler, M.; Russo, G.; Biedermann, L.; Hombach, M.; Rogler, G.; Moelling, K. Long-term changes of bacterial and viral compositions in the intestine of a recovered Clostridium difficile patient after fecal microbiota transplantation. Mol. Case Stud. 2016, 2, a000448. [Google Scholar] [CrossRef] [Green Version]
- Limon, J.J.; Skalski, J.H.; Underhill, D.M. Commensal Fungi in Health and Disease. Cell Host Microbe 2017, 22, 156–165. [Google Scholar] [CrossRef]
- Sokol, H.; Leducq, V.; Aschard, H.; Pham, H.P.; Jegou, S.; Landman, C.; Cohen, D.; Liguori, G.; Bourrier, A.; Nion-Larmurier, I.; et al. Fungal microbiota dysbiosis in IBD. Gut 2017, 66, 1039–1048. [Google Scholar] [CrossRef]
- Leonardi, I.; Paramsothy, S.; Doron, I.; Semon, A.; Kaakoush, N.O.; Clemente, J.C.; Faith, J.J.; Borody, T.J.; Mitchell, H.M.; Colombel, J.-F.; et al. Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative Colitis. Cell Host Microbe 2020, 27, 823–829.e3. [Google Scholar] [CrossRef]
- Zuo, T.; Wong, S.H.; Cheung, C.P.; Lam, K.; Lui, R.; Cheung, K.; Zhang, F.; Tang, W.; Ching, J.Y.L.; Wu, J.C.Y.; et al. Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection. Nat. Commun. 2018, 9, 3663. [Google Scholar] [CrossRef] [Green Version]
- Seekatz, A.M.; Theriot, C.M.; Rao, K.; Chang, Y.-M.; Freeman, A.E.; Kao, J.Y.; Young, V.B. Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection. Anaerobe 2018, 53, 64–73. [Google Scholar] [CrossRef]
- Gotoh, K.; Sakaguchi, Y.; Kato, H.; Osaki, H.; Jodai, Y.; Wakuda, M.; Také, A.; Hayashi, S.; Morita, E.; Sugie, T.; et al. Fecal microbiota transplantation as therapy for recurrent Clostridioides difficile infection is associated with amelioration of delirium and accompanied by changes in fecal microbiota and the metabolome. Anaerobe 2022, 73, 102502. [Google Scholar] [CrossRef]
- Yang, M.; Gu, Y.; Li, L.; Liu, T.; Song, X.; Sun, Y.; Cao, X.; Wang, B.; Jiang, K.; Cao, H. Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside. Nutrients 2021, 13, 3143. [Google Scholar] [CrossRef]
- Litvak, Y.; Mon, K.K.; Nguyen, H.; Chanthavixay, G.; Liou, M.; Velazquez, E.M.; Kutter, L.; Alcantara, M.A.; Byndloss, M.; Tiffany, C.R.; et al. Commensal Enterobacteriaceae Protect against Salmonella Colonization through Oxygen Competition. Cell Host Microbe 2019, 25, 128–139.e5. [Google Scholar] [CrossRef] [Green Version]
- Kapitan, M.; Niemiec, M.J.; Steimle, A.; Frick, J.S.; Jacobsen, I.D. Fungi as Part of the Microbiota and Interactions with Intestinal Bacteria. Curr. Top. Microbiol. Immunol. 2019, 422, 265–301. [Google Scholar] [PubMed]
- Shelby, R.D.; Janzow, G.E.; Mashburn-Warren, L.; Galley, J.; Tengberg, N.; Navarro, J.; Conces, M.; Bailey, M.T.; Goodman, S.D.; Besner, G.E. A novel probiotic therapeutic in a murine model of Clostridioides difficile colitis. Gut Microbes 2020, 12, 1814119. [Google Scholar] [CrossRef] [PubMed]
- Kamada, N.; Chen, G.Y.; Inohara, N.; Núñez, G. Control of pathogens and pathobionts by the gut microbiota. Nat. Immunol. 2013, 14, 685–690. [Google Scholar] [CrossRef] [PubMed]
- Fan, D.; Coughlin, L.A.; Neubauer, M.M.; Kim, J.; Kim, M.S.; Zhan, X.; Simms-Waldrip, T.R.; Xie, Y.; Hooper, L.V.; Koh, A.Y. Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nat. Med. 2015, 21, 808–814. [Google Scholar] [CrossRef] [PubMed]
- Hudson, L.E.; Anderson, S.E.; Corbett, A.H.; Lamb, T.J. Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clin. Microbiol. Rev. 2017, 30, 191–231. [Google Scholar] [CrossRef] [Green Version]
- Mullish, B.H.; McDonald, J.A.K.; Pechlivanis, A.; Allegretti, J.R.; Kao, D.; Barker, G.F.; Kapila, D.; Petrof, E.O.; Joyce, S.A.; Gahan, C.G.M.; et al. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection. Gut 2019, 68, 1791–1800. [Google Scholar] [CrossRef] [Green Version]
- León, M.; Bastías, R. Virulence reduction in bacteriophage resistant bacteria. Front. Microbiol. 2015, 6, 343. [Google Scholar] [CrossRef] [Green Version]
- Czerucka, D.; Piche, T.; Rampal, P. Review article: Yeast as probiotics -Saccharomyces boulardii. Aliment. Pharmacol. Ther. 2007, 26, 767–778. [Google Scholar] [CrossRef]
- Hagi, T.; Geerlings, S.Y.; Nijsse, B.; Belzer, C. The effect of bile acids on the growth and global gene expression profiles in Akkermansia muciniphila. Appl. Microbiol. Biotechnol. 2020, 104, 10641–10653. [Google Scholar] [CrossRef]
- Di Ciaula, A.; Garruti, G.; Baccetto, R.L.; Molina-Molina, E.; Bonfrate, L.; Portincasa, P.; Wang, D.Q. Bile Acid Physiology. Ann. Hepatol. 2018, 16, 4–14. [Google Scholar] [CrossRef]
- Donaldson, G.P.; Ladinsky, M.S.; Yu, K.B.; Sanders, J.G.; Yoo, B.B.; Chou, W.-C.; Conner, M.E.; Earl, A.M.; Knight, R.; Bjorkman, P.J.; et al. Gut microbiota utilize immunoglobulin A for mucosal colonization. Science 2018, 360, 795–800. [Google Scholar] [CrossRef] [Green Version]
- Bollinger, R.R.; Everett, M.L.; Palestrant, D.; Love, S.D.; Lin, S.S.; Parker, W. Human secretory immunoglobulin A may contribute to biofilm formation in the gut. Immunology 2003, 109, 580–587. [Google Scholar] [CrossRef]
- Mathias, A.; Duc, M.; Favre, L.; Benyacoub, J.; Blum, S.; Corthésy, B. Potentiation of Polarized Intestinal Caco-2 Cell Responsiveness to Probiotics Complexed with Secretory IgA. J. Biol. Chem. 2010, 285, 33906–33913. [Google Scholar] [CrossRef] [Green Version]
- Yang, Y.; Palm, N.W. Immunoglobulin a and the Microbiome. Curr. Opin. Microbiol. 2020, 56, 89–96. [Google Scholar] [CrossRef]
- Farhadi, A.; Banan, A.; Fields, J.; Keshavarzian, A. Intestinal barrier: An interface between health and disease. J. Gastroenterol. Hepatol. 2003, 18, 479–497. [Google Scholar] [CrossRef]
- Sicard, J.-F.; Le Bihan, G.; Vogeleer, P.; Jacques, M.; Harel, J. Interactions of Intestinal Bacteria with Components of the Intestinal Mucus. Front. Cell. Infect. Microbiol. 2017, 7, 387. [Google Scholar] [CrossRef] [Green Version]
- Maynard, C.L.; Elson, C.O.; Hatton, R.D.; Weaver, C.T. Reciprocal interactions of the intestinal microbiota and immune system. Nature 2012, 489, 231–241. [Google Scholar] [CrossRef] [Green Version]
- Ohta, H.; Sunden, Y.; Yokoyama, N.; Osuga, T.; Lim, S.Y.; Tamura, Y.; Morishita, K.; Nakamura, K.; Yamasaki, M.; Takiguchi, M. Expression of apical junction complex proteins in duodenal mucosa of dogs with inflammatory bowel disease. Am. J. Vet. Res. 2014, 75, 746–751. [Google Scholar] [CrossRef]
- Suzuki, T. Regulation of the intestinal barrier by nutrients: The role of tight junctions. Anim. Sci. J. 2020, 91, e13357. [Google Scholar] [CrossRef] [Green Version]
- Landy, J.; Ronde, E.; English, N.; Clark, S.K.; Hart, A.L.; Knight, S.C.; Ciclitira, P.J.; Al-Hassi, H.O. Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer. World J. Gastroenterol. 2016, 22, 3117–3126. [Google Scholar] [CrossRef]
- Jergens, A.E.; Simpson, K.W. Inflammatory Bowel Disease in Veterinary Medicine. Front. Biosci. (Elite Ed.) 2012, 4, 1404–1419. [Google Scholar] [CrossRef] [PubMed]
- Schaeffler, H.; Breitrueck, A. Clostridium difficile–from Colonization to Infection. Front. Microbiol. 2018, 9, 646. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Leipig-Rudolph, M.; Busch, K.; Prescott, J.F.; Gohari, I.M.; Leutenegger, C.M.; Hermanns, W.; Wolf, G.; Hartmann, K.; Verspohl, J.; Unterer, S. Intestinal Lesions in Dogs with Acute Hemorrhagic Diarrhea Syndrome Associated with Netf-Positive Clostridium Perfringens Type A. J. Vet. Diagn. Investig. 2018, 30, 495–503. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mazzaferro, E.M. Update on Canine Parvoviral Enteritis. Vet. Clin. N. Am. Small Anim. Pract. 2020, 50, 1307–1325. [Google Scholar] [CrossRef] [PubMed]
- Gai, X.; Wang, H.; Li, Y.; Zhao, H.; He, C.; Wang, Z.; Zhao, H. Fecal Microbiota Transplantation Protects the Intestinal Mucosal Barrier by Reconstructing the Gut Microbiota in a Murine Model of Sepsis. Front. Cell. Infect. Microbiol. 2021, 11, 912. [Google Scholar] [CrossRef]
- Na, K.; Wei, J.; Zhang, L.; Fang, Y.; Li, X.; Lu, S.; Guo, X. Effects of chitosan oligosaccharides (COS) and FMT from COS-dosed mice on intestinal barrier function and cell apoptosis. Carbohydr. Polym. 2022, 297, 120043. [Google Scholar] [CrossRef]
- Assimakopoulos, S.F.; Papadopoulou, I.; Bantouna, D.; de Lastic, A.-L.; Rodi, M.; Mouzaki, A.; Gogos, C.A.; Zolota, V.; Maroulis, I. Fecal Microbiota Transplantation and Hydrocortisone Ameliorate Intestinal Barrier Dysfunction and Improve Survival in a Rat Model of Cecal Ligation and Puncture-Induced Sepsis. Shock 2021, 55, 666–675. [Google Scholar] [CrossRef]
- Kamada, N.; Seo, S.-U.; Chen, G.Y.; Núñez, G. Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 2013, 13, 321–335. [Google Scholar] [CrossRef]
- Hiippala, K.; Jouhten, H.; Ronkainen, A.; Hartikainen, A.; Kainulainen, V.; Jalanka, J.; Satokari, R. The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation. Nutrients 2018, 10, 988. [Google Scholar] [CrossRef] [Green Version]
- Zhai, Q.; Feng, S.; Arjan, N.; Chen, W. A Next Generation Probiotic, Akkermansia Muciniphila. Crit. Rev. Food Sci. Nutr. 2019, 59, 3227–3236. [Google Scholar] [CrossRef]
- De Luca, F.; Shoenfeld, Y. The microbiome in autoimmune diseases. Clin. Exp. Immunol. 2019, 195, 74–85. [Google Scholar] [CrossRef] [Green Version]
- Shen, Z.-H.; Zhu, C.-X.; Quan, Y.-S.; Yang, Z.-Y.; Wu, S.; Luo, W.-W.; Tan, B.; Wang, X.-Y. Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation. World J. Gastroenterol. 2018, 24, 5–14. [Google Scholar] [CrossRef]
- Brandl, K.; Plitas, G.; Schnabl, B.; DeMatteo, R.P.; Pamer, E.G. Myd88-Mediated Signals Induce the Bactericidal Lectin Regiii Gamma and Protect Mice against Intestinal Listeria Monocytogenes Infection. J. Exp. Med. 2007, 204, 1891–1900. [Google Scholar] [CrossRef]
- Menendez, A.; Willing, B.P.; Montero, M.; Wlodarska, M.; So, C.C.; Bhinder, G.; Vallance, B.A.; Finlay, B.B. Bacterial Stimulation of the Tlr-Myd88 Pathway Modulates the Homeostatic Expression of Ileal Paneth Cell A-Defensins. J. Innate Immun. 2013, 5, 39–49. [Google Scholar] [CrossRef]
- Nakamura, K.; Sakuragi, N.; Takakuwa, A.; Ayabe, T. Paneth cell α-defensins and enteric microbiota in health and disease. Biosci. Microbiota Food Health 2016, 35, 57–67. [Google Scholar] [CrossRef] [Green Version]
- Habil, N.; Abate, W.; Beal, J.; Foey, A. Heat-killed probiotic bacteria differentially regulate colonic epithelial cell production of human β-defensin-2: Dependence on inflammatory cytokines. Benef. Microbes 2014, 5, 483–495. [Google Scholar] [CrossRef]
- Chassaing, B.; Darfeuille-Michaud, A. The Commensal Microbiota and Enteropathogens in the Pathogenesis of Inflammatory Bowel Diseases. Gastroenterology 2011, 140, 1720–1728.e3. [Google Scholar] [CrossRef]
- Sun, M.; Wu, W.; Liu, Z.; Cong, Y. Microbiota Metabolite Short Chain Fatty Acids, Gpcr, and Inflammatory Bowel Diseases. J. Gastroenterol. 2017, 52, 1–8. [Google Scholar] [CrossRef]
- Ratajczak, W.; Rył, A.; Mizerski, A.; Walczakiewicz, K.; Sipak, O.; Laszczyńska, M. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs). Acta Biochim. Pol. 2019, 66, 1–12. [Google Scholar] [CrossRef] [Green Version]
- Martin-Gallausiaux, C.; Marinelli, L.; Blottiere, H.M.; Larraufie, P.; Lapaque, N. SCFA: Mechanisms and functional importance in the gut. Proc. Nutr. Soc. 2021, 80, 37–49. [Google Scholar] [CrossRef]
- Gomaa, E.Z. Human gut microbiota/microbiome in health and diseases: A review. Antonie Leeuwenhoek 2020, 113, 2019–2040. [Google Scholar] [CrossRef] [PubMed]
- Kelly, C.J.; Zheng, L.; Campbell, E.L.; Saeedi, B.; Scholz, C.C.; Bayless, A.J.; Wilson, K.E.; Glover, L.E.; Kominsky, D.J.; Magnuson, A.; et al. Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. Cell Host Microbe 2015, 17, 662–671. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liptak, R.; Gromova, B.; Maronek, M.; Gardlik, R. Reverse phenotype transfer via fecal microbial transplantation in inflammatory bowel disease. Med. Hypotheses 2019, 122, 41–44. [Google Scholar] [CrossRef] [PubMed]
- Tan, J.; McKenzie, C.; Potamitis, M.; Thorburn, A.N.; Mackay, C.R.; Macia, L. The Role of Short-Chain Fatty Acids in Health and Disease. Adv. Immunol. 2014, 121, 91–119. [Google Scholar] [CrossRef] [PubMed]
- Fellows, R.; Denizot, J.; Stellato, C.; Cuomo, A.; Jain, P.; Stoyanova, E.; Balázsi, S.; Hajnády, Z.; Liebert, A.; Kazakevych, J.; et al. Microbiota Derived Short Chain Fatty Acids Promote Histone Crotonylation in the Colon through Histone Deacetylases. Nat. Commun. 2018, 9, 105. [Google Scholar] [CrossRef] [Green Version]
- Wang, H.-B.; Wang, P.-Y.; Wang, X.; Wan, Y.-L.; Liu, Y.-C. Butyrate Enhances Intestinal Epithelial Barrier Function via Up-Regulation of Tight Junction Protein Claudin-1 Transcription. Dig. Dis. Sci. 2012, 57, 3126–3135. [Google Scholar] [CrossRef]
- Zhao, Y.; Chen, F.; Wu, W.; Sun, M.; Bilotta, A.J.; Yao, S.; Xiao, Y.; Huang, X.; Eaves-Pyles, T.D.; Golovko, G.; et al. GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3. Mucosal Immunol. 2018, 11, 752–762. [Google Scholar] [CrossRef] [Green Version]
- Macia, L.; Tan, J.; Vieira, A.T.; Leach, K.; Stanley, D.; Luong, S.; Maruya, M.; McKenzie, C.l.; Hijikata, A.; Wong, C.; et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat. Commun. 2015, 6, 6734. [Google Scholar] [CrossRef] [Green Version]
- Chiang, J.Y.L. Bile Acid Metabolism and Signaling. Compr. Physiol. 2013, 3, 1191–1212. [Google Scholar] [CrossRef] [Green Version]
- Hollenbach, E.; Neumann, M.; Vieth, M.; Roessner, A.; Malfertheiner, P.; Naumann, M. Inhibition of P38 Map Kinase- and Rick/Nf-Kappab-Signaling Suppresses Inflammatory Bowel Disease. FASEB J. 2004, 18, 1550–1552. [Google Scholar] [CrossRef]
- Lee, G.R. The balance of Th17 versus treg cells in autoimmunity. Int. J. Mol. Sci. 2018, 19, 730. [Google Scholar] [CrossRef] [Green Version]
- Buonomo, E.L.; Petri, W.A. The microbiota and immune response during Clostridium difficile infection. Anaerobe 2016, 41, 79–84. [Google Scholar] [CrossRef] [Green Version]
- Ay, C.D. Neutrophil to lymphocyte ratio as a prognostic biomarker in puppies with acute diarrhea. J. Vet. Emerg. Crit. Care 2021, 32, 83–89. [Google Scholar] [CrossRef]
- Heilmann, R.M.; Guard, M.M.; Steiner, J.M.; Suchodolski, J.S.; Unterer, S. Fecal markers of inflammation, protein loss, and microbial changes in dogs with the acute hemorrhagic diarrhea syndrome (AHDS). J. Vet. Emerg. Crit. Care 2017, 27, 586–589. [Google Scholar] [CrossRef]
- Wang, Y.; Wiesnoski, D.H.; Helmink, B.A.; Gopalakrishnan, V.; Choi, K.; Dupont, H.L.; Jiang, Z.-D.; Abu-Sbeih, H.; Sanchez, C.A.; Chang, C.-C.; et al. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. Nat. Med. 2018, 24, 1804–1808. [Google Scholar] [CrossRef]
- Burrello, C.; Garavaglia, F.; Cribiù, F.M.; Ercoli, G.; Lopez, G.; Troisi, J.; Colucci, A.; Guglietta, S.; Carloni, S.; Guglielmetti, S.; et al. Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells. Nat. Commun. 2018, 9, 5184. [Google Scholar] [CrossRef] [Green Version]
- Qiu, J.; Wu, C.; Gao, Q.; Li, S.; Li, Y. Effect of Fecal Microbiota Transplantation on the Tgf-Β1/Smad Signaling Pathway in Rats with Tnbs-Induced Colitis. Ann. Transl. Med. 2022, 10, 825. [Google Scholar] [CrossRef]
- Wang, Y.; Ren, R.; Sun, G.; Peng, L.; Tian, Y.; Yang, Y. Pilot study of cytokine changes evaluation after fecal microbiota transplantation in patients with ulcerative colitis. Int. Immunopharmacol. 2020, 85, 106661. [Google Scholar] [CrossRef]
- Miquel, S.; Martín, R.; Rossi, O.; Bermúdez-Humarán, L.G.; Chatel, J.M.; Sokol, H.; Thomas, M.; Wells, J.M.; Langella, P. Faecalibacterium Prausnitzii and Human Intestinal Health. Curr. Opin. Microbiol. 2013, 16, 255–261. [Google Scholar] [CrossRef]
- Peterson, C.T.; Sharma, V.; Elmén, L.; Peterson, S.N. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota. Clin. Exp. Immunol. 2015, 179, 363–377. [Google Scholar] [CrossRef] [Green Version]
- Górski, A.; Dąbrowska, K.; Międzybrodzki, R.; Weber-Dąbrowska, B.; Łusiak-Szelachowska, M.; Jończyk-Matysiak, E.; Borysowski, J. Phages and Immunomodulation. Future Microbiol. 2017, 12, 905–914. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Maronek, M.; Link, R.; Ambro, L.; Gardlik, R. Phages and Their Role in Gastrointestinal Disease: Focus on Inflammatory Bowel Disease. Cells 2020, 9, 1013. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Morrison, D.J.; Preston, T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 2016, 7, 189–200. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ridlon, J.M.; Kang, D.J.; Hylemon, P.B.; Bajaj, J.S. Bile Acids and the Gut Microbiome. Curr. Opin. Gastroenterol. 2014, 30, 332–338. [Google Scholar] [CrossRef] [PubMed]
- Inagaki, T.; Moschetta, A.; Lee, Y.-K.; Peng, L.; Zhao, G.; Downes, M.; Yu, R.T.; Shelton, J.M.; Richardson, J.A.; Repa, J.J.; et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc. Natl. Acad. Sci. USA 2006, 103, 3920–3925. [Google Scholar] [CrossRef] [Green Version]
- Gadaleta, R.M.; Van Erpecum, K.J.; Oldenburg, B.; Willemsen, E.C.L.; Renooij, W.; Murzilli, S.; Klomp, L.W.J.; Siersema, P.D.; Schipper, M.E.; Danese, S.; et al. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut 2011, 60, 463–472. [Google Scholar] [CrossRef]
- Biagioli, M.; Carino, A.; Cipriani, S.; Francisci, D.; Marchianò, S.; Scarpelli, P.; Sorcini, D.; Zampella, A.; Fiorucci, S. The Bile Acid Receptor Gpbar1 Regulates the M1/M2 Phenotype of Intestinal Macrophages and Activation of Gpbar1 Rescues Mice from Murine Colitis. J. Immunol. 2017, 199, 718–733. [Google Scholar] [CrossRef] [Green Version]
- Högenauer, K.; Arista, L.; Schmiedeberg, N.; Werner, G.; Jaksche, H.; Bouhelal, R.; Nguyen, D.G.; Bhat, B.G.; Raad, L.; Rauld, C.; et al. G-Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5) Agonists Reduce the Production of Proinflammatory Cytokines and Stabilize the Alternative Macrophage Phenotype. J. Med. Chem. 2014, 57, 10343–10354. [Google Scholar] [CrossRef]
- Fujisaka, S. The Role of Adipose Tissue M1/M2 Macrophages in Type 2 Diabetes Mellitus. Diabetol. Int. 2021, 12, 74–79. [Google Scholar] [CrossRef]
- Monaghan, T.; Mullish, B.H.; Patterson, J.; Wong, G.K.; Marchesi, J.R.; Xu, H.; Jilani, T.; Kao, D. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway. Gut Microbes 2019, 10, 142–148. [Google Scholar] [CrossRef] [Green Version]
- McFarland, L.V.; Evans, C.T.; Goldstein, E.J.C. Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis. Front. Med. (Lausanne) 2018, 5, 124. [Google Scholar] [CrossRef] [Green Version]
- Ouwerkerk, J.P.; de Vos, W.M.; Belzer, C. Glycobiome: Bacteria and mucus at the epithelial interface. Best Pract. Res. Clin. Gastroenterol. 2013, 27, 25–38. [Google Scholar] [CrossRef]
- Wang, H.; Lu, Y.; Yan, Y.; Tian, S.; Zheng, D.; Leng, D.; Wang, C.; Jiao, J.; Wang, Z.; Bai, Y. Promising Treatment for Type 2 Diabetes: Fecal Microbiota Transplantation Reverses Insulin Resistance and Impaired Islets. Front. Cell. Infect. Microbiol. 2020, 9, 455. [Google Scholar] [CrossRef] [Green Version]
- Millan, B.; Laffin, M.; Madsen, K. Fecal Microbiota Transplantation: Beyond Clostridium difficile. Curr. Infect. Dis. Rep. 2017, 19, 31. [Google Scholar] [CrossRef]
- Puddu, A.; Sanguineti, R.; Montecucco, F.; Viviani, G.L. Evidence for the Gut Microbiota Short-Chain Fatty Acids as Key Pathophysiological Molecules Improving Diabetes. Mediat. Inflamm. 2014, 2014, 162021. [Google Scholar] [CrossRef] [Green Version]
- Wu, Y.; Zhou, A.; Tang, L.; Lei, Y.; Tang, B.; Zhang, L. Bile Acids: Key Regulators and Novel Treatment Targets for Type 2 Diabetes. J. Diabetes Res. 2020, 2020, 6138438. [Google Scholar] [CrossRef]
- Miller, E.J.; Brines, C.M. Canine Diabetes Mellitus Associated Ocular Disease. Top. Companion Anim. Med. 2018, 33, 29–34. [Google Scholar] [CrossRef]
- Lidbury, J.A.; Cook, A.K.; Steiner, J.M. Hepatic encephalopathy in dogs and cats. J. Vet. Emerg. Crit. Care 2016, 26, 471–487. [Google Scholar] [CrossRef]
- Seo, M.-G.; Park, S.; Han, S.; Kim, A.-Y.; Lee, E.-J.; Jeong, K.-S.; Hong, I.-H. Long-term treatment of allogeneic adipose-derived stem cells in a dog with rheumatoid arthritis. J. Vet. Sci. 2022, 23, e61. [Google Scholar] [CrossRef]
- Tang, J.; Li, Y.; Lyon, K.; Camps, J.; Dalton, S.; Ried, T.; Zhao, S. Cancer driver–passenger distinction via sporadic human and dog cancer comparison: A proof-of-principle study with colorectal cancer. Oncogene 2014, 33, 814–822. [Google Scholar] [CrossRef] [Green Version]
- Heim, D.; Kuster, S.; Willi, B. Antibiotic-resistant bacteria in dogs and cats: Recommendations for -owners. Schweiz Arch. Tierheilkd. 2020, 162, 141–151. [Google Scholar] [CrossRef] [PubMed]
- German, A.J. The Growing Problem of Obesity in Dogs and Cats. J. Nutr. 2006, 136, 1940S–1946S. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Enerson, B.E.; Lin, A.; Lu, B.; Zhao, H.; Lawton, M.P.; Floyd, E. Acute Drug-Induced Vascular Injury in Beagle Dogs: Pathology and Correlating Genomic Expression. Toxicol. Pathol. 2006, 34, 27–32. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sanchez, S.B.; Pilla, R.; Sarawichitr, B.; Gramenzi, A.; Marsilio, F.; Steiner, J.M.; Lidbury, J.A.; Woods, G.R.; German, A.J.; Suchodolski, J.S. Fecal microbiota in client-owned obese dogs changes after weight loss with a high-fiber-high-protein diet. PeerJ 2020, 8, e9706. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Li, K.; Yang, J.; Zhou, X.; Wang, H.; Ren, Y.; Huang, Y.; Liu, H.; Zhong, Z.; Peng, G.; Zheng, C.; et al. The Mechanism of Important Components in Canine Fecal Microbiota Transplantation. Vet. Sci. 2022, 9, 695. https://doi.org/10.3390/vetsci9120695
Li K, Yang J, Zhou X, Wang H, Ren Y, Huang Y, Liu H, Zhong Z, Peng G, Zheng C, et al. The Mechanism of Important Components in Canine Fecal Microbiota Transplantation. Veterinary Sciences. 2022; 9(12):695. https://doi.org/10.3390/vetsci9120695
Chicago/Turabian StyleLi, Kerong, Jie Yang, Xiaoxiao Zhou, Huan Wang, Yuxin Ren, Yunchuan Huang, Haifeng Liu, Zhijun Zhong, Guangneng Peng, Chengli Zheng, and et al. 2022. "The Mechanism of Important Components in Canine Fecal Microbiota Transplantation" Veterinary Sciences 9, no. 12: 695. https://doi.org/10.3390/vetsci9120695